Encompass Health Corporation reported $6.21B of revenue over the trailing twelve months, +9.5% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $6.21B (to Q2 2026). Net income: $621M, trailing twelve months to Q2 2026. Free cash flow: $413M, trailing twelve months to Q2 2026. Operating margin: 18%, trailing twelve months to Q2 2026.

EHCEncompass Health Corporation

Healthcare

$123.20-0.17% 1Y

$123.20

$93.6552 weeks$126.70

EHC as reported

Encompass Health Corporation reported $6.21B of revenue over the trailing twelve months, +9.5% on the year before. 10 reported series are charted on this page, each one as filed.

$6.21B

Revenue, trailing twelve months · to Q2 2026 · +9.5% against the twelve months before

Net income: $621M
Net income · +19% year on year · trailing twelve months to Q2 2026
Free cash flow: $413M
Free cash flow · −5.9% year on year · trailing twelve months to Q2 2026
Operating margin: 18%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for EHC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$6.21B	+9.5%	Q2 2026
Net income	$621M	+19%	Q2 2026
EPS	$6.14	+20%	Q2 2026
Operating margin	18%	n/a	Q2 2026
Net margin	10.0%	n/a	Q2 2026
ROE	24%	n/a	Q2 2026
ROA	8.1%	n/a	Q2 2026
ROIC	17%	n/a	Q2 2026
Free cash flow	$413M	−5.9%	Q2 2026
P/E	20.1	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.